Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 2,145 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Site Clear all

Conditions: Hypertension, Prehypertension
Interventions: Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years to 65 Years
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Distal Radius Fractures
Interventions: Intramedullary Radius Fixation (Micronail), Volar Plate Fixation; Device · Procedure
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Obesity, Food Habits
Interventions: General Nutrition Recommendations, Breakfast Recommendation, No Breakfast Recommendation; Behavioral
Lead sponsor: David Allison, Phd; Other
Eligibility: 20 Years to 65 Years
Enrollment: 309 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: Birmingham, Alabama • Denver, Colorado • Boston, Massachusetts + 1 more

Conditions: Disc Herniation
Interventions: Discogen Low pulsed ultrasound treatment, Discogen Sham Treatment; Device
Lead sponsor: Columbia University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Sunscreening Agents
Interventions: CLM Original; Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation
Interventions: Hepatitis C Immune Globulin Intravenous (Human) 5%; Biological
Lead sponsor: ADMA Biologics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Phoenix, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Arthrofibrosis of Knee
Interventions: Low-Dose External Beam Irradiation, Hinged Revision Total Knee Arthroplasty; Radiation · Procedure
Lead sponsor: Mount Sinai Hospital, Canada; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Los Angeles, California • Salt Lake City, Utah

Conditions: Ovarian Cysts
Interventions: Transvaginal Ultrasound Educational DVD; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: Not listed
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania • West Reading, Pennsylvania • Wynnewood, Pennsylvania

Conditions: Hypertension
Interventions: High Intensity Intervention, Low Intensity Intervention, All- 6 month pharmacist intervention; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Hepatitis C, Medication Adherence
Interventions: AiCure, AiCure with gamification; Device
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Head and Neck Cancer
Interventions: TAK-981, Cetuximab, Avelumab, TAK-981 + Cetuximab, TAK-981 + Avelumab; Drug · Biological · Combination Product
Lead sponsor: Presage Biosciences; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 6
States / cities: Ann Arbor, Michigan • New York, New York • North New Hyde Park, New York + 2 more

Conditions: Actinic Keratosis
Interventions: Diclofenac sodium, Placebo; Drug · Other
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 31
States / cities: Fremont, California • Long Beach, California • Newport Beach, California + 27 more

Conditions: Major Depressive Disorder
Interventions: NRX-1074 1 mg, Placebo, NRX-1074 5 mg, NRX-1074 10 mg; Drug
Lead sponsor: Naurex, Inc, an affiliate of Allergan plc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 12
States / cities: Oakland, California • Skokie, Illinois • Wichita, Kansas + 9 more

Conditions: Corneal Transplant Failure
Interventions: Corneal Donor Tissue with Cross Linking, Corneal Donor Tissue without Cross Linking; Procedure
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 12
States / cities: Irvine, California • Los Angeles, California • San Francisco, California + 9 more

Conditions: Surgical Site Infection
Interventions: DFA-02, Placebo; Drug
Lead sponsor: Dr. Reddy's Laboratories Limited; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Florence, Alabama • Tampa, Florida • Columbus, Ohio + 2 more

Conditions: Wound Heal, Ulcer
Interventions: InnovaMatrix® AC; Device
Lead sponsor: ConvaTec Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 235 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Fresno, California • Los Angeles, California • San Diego, California + 16 more

Conditions: Tooth Extraction Status Nos
Interventions: tooth extraction, CBCT scan, Anesthesia, clinical measurements, Biodegradable sponge (type I bovine collagen), 10µg of pSil-miR200c, cross mattress suture, 10µg of PMIS miR200a plasmids, 5µg of pSil-miR200c and 5µg of PMIS miR200a, Blood, Photos/videos, Wound fluid, saliva, periapical xray, PVS impression; Procedure · Radiation · Drug + 1 more
Lead sponsor: Gustavo Avila-Ortiz DDS, MS, PhD; Other
Eligibility: 25 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Wounds
Interventions: Stasilon; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Trigger Finger, Pain
Interventions: Ipsilateral Scratch Task, Motor Distraction Task; Behavioral
Lead sponsor: Grand Canyon University; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gilbert, Arizona

Conditions: Acne Vulgaris
Interventions: Tazarotene Foam, Vehicle Foam; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 254 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Soft Tissue Injuries
Interventions: Licart™ (diclofenac epolamine) topical system; Drug
Lead sponsor: IBSA Institut Biochimique SA; Industry
Eligibility: 6 Years to 45 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 11
States / cities: Little Rock, Arkansas • La Palma, California • DeLand, Florida + 8 more

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Decision Support, Educational Intervention Only; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: In-hospital Cardiac Arrest, Cardiopulmonary Resuscitation
Interventions: SAMURAI PICU Bundle; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 5
States / cities: Chicago, Illinois • Akron, Ohio • Charleston, South Carolina + 2 more

Conditions: Parkinson Disease, Autonomic Dysfunction, Depression
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Effect of Reducing Sedentary Behavior on Blood Pressure

Fixation of Unstable Distal Radius Fractures

Study of the Effectiveness of Breakfast Recommendations On Reducing Body Weight

Discogen for Low Back Pain

Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Stiffness and Low Dose Irradiation RCT

Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents

Trial of Low and High Intensity Strategies to Maintain BP Control

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

DFA-02 in Patients Undergoing Colorectal Surgery

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial

Hemostatic Textile to Control Bleeding at Donor Graft Sites

Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation

Situation Awareness Incorporating Multidisciplinary Teams Reduce Arrests In the Pediatric ICU

Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease